Clinical Trial Update: Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of dapagliflozin on diastolic dysfunction in patients with type 2 diabetes mellitus. Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Yonsei University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED